glp-1 agonist weight loss medications alternatives How are transforming diabetes and treatment GLP-1 Weight Loss NYC |

However, for patients with type 2 diabetes or obesity who also have dyslipidaemia, these agents may provide complementary lipid benefits alongside their primary therapeutic effects

SGLT2 inhibitors are now authorised for the treatment of chronic kidney disease and heart failure in individuals with or without T2DM [1, 2]

7, 2026, by BMJ , dont surprise Meghan Salamon, a dietitian at the Weight Center at Harvard-affiliated Massachusetts General Hospital

Semaglutide | Drugs | BNF NICE

Research suggests that protein intake, particularly from sources such as fish, poultry, eggs, and legumes, may increase postprandial GLP-1 secretion

Now access to those medications is anything but certain.